NuvaRing

Known as: Nuvaring® 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2016
02420002016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The contraceptive vaginal ring is a novel contraceptive method that offers unique advantages. Intravaginal delivery of both… (More)
  • table 1
  • figure 1
Is this relevant?
2008
2008
OBJECTIVES To investigate the real-life clinical experience of NuvaRing users in Germany. METHODS An open-label, prospective… (More)
Is this relevant?
2008
2008
AIM To evaluate the effect of the vaginally inserted hormone-releasing system NuvaRing on carbohydrate and lipid metabolism and… (More)
Is this relevant?
2007
2007
OBJECTIVES To assess clinical experience with NuvaRing in daily practice in Switzerland, including a large subgroup of young… (More)
Is this relevant?
2006
2006
PURPOSE This randomized multicenter, open-label, trial compared efficacy, acceptability, tolerability and compliance of NuvaRing… (More)
Is this relevant?
2006
2006
OBJECTIVES The combined contraceptive vaginal ring (NuvaRing) has been shown to be safe and effective, with high levels of user… (More)
Is this relevant?
2005
2005
We investigated the effects of NuvaRing on endometrial histology in a 2-year open-label, multicenter trial in 103 premenopausal… (More)
Is this relevant?
2004
2004
This study compared the lipid profile after three and six cycles of treatment with NuvaRing delivering 15 microg ethinylestradiol… (More)
Is this relevant?
2001
2001
OBJECTIVE To assess the effects of the combined contraceptive vaginal ring NuvaRing on ovarian function. DESIGN Randomized… (More)
  • table 2
Is this relevant?
2000
2000
OBJECTIVE To assess the pharmacokinetics of etonogestrel and ethinylestradiol released from a novel combined contraceptive… (More)
Is this relevant?